Quantitative Reverse Transcription-Polymerase Chain Reaction of Circulating Thyroglobulin Messenger Ribonucleic Acid for Monitoring Patients with Thyroid Carcinoma1

Autor: Carole A. Spencer, R. Michael Tuttle, Leonard Wartofsky, Matthew D. Ringel, Pina L. Balducci-Silano, Gary L. Francis, Yvonne H. Sparling, Paul W. Ladenson, Jeffery S. Anderson, Michael A. Levine, Jill L. Silverman, Kenneth D. Burman
Rok vydání: 1999
Předmět:
Zdroj: The Journal of Clinical Endocrinology & Metabolism. 84:4037-4042
ISSN: 1945-7197
0021-972X
DOI: 10.1210/jcem.84.11.6164
Popis: Patients with thyroid cancer are monitored for disease recurrence by measurement of serum thyroglobulin (Tg) and iodine-131 (131I) scanning. To enhance sensitivity and to circumvent antibodies that interfere with Tg immunoassays, we have developed RT-PCR assays that detect circulating thyroid messenger RNA (mRNA) transcripts. We now report results using a sensitive quantitative Tg mRNA assay (Taqman; ABI, Foster City, CA) in comparison with immunoassay in patients previously treated for thyroid cancer. We evaluated 107 patients: 84 during T4 therapy, 14 after T4 withdrawal, and 9 at both time points. All patients had near-total thyroidectomy, and 92% received postoperative 131I. Serum TSH, Tg protein, and Tg mRNA were measured. Patients were grouped based on most recent 131I scan or pathologically confirmed disease as having no detectable thyroid tissue (n = 33), thyroid bed uptake (n = 37), cervical/regional adenopathy (n = 21), or distant metastases (n = 16). During T4 therapy, median (range) Tg mRNA va...
Databáze: OpenAIRE